Benzinga - Gainers
- Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.
- Histogen Inc. (NASDAQ: HSTO) climbed 60% to $1.39 after the company announced issuance of a US patent covering CTS-2090 methods of use.
- QualTek Services Inc. (NASDAQ: QTEK) gained 56.4% to $0.4379. QualTek secured new money financing.
- AirNet Technology Inc. (NASDAQ: ANTE) climbed 38.3% to $1.12.
- Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) gained 38% to $13.66.
- Lixiang Education Holding Co., Ltd. (NASDAQ: LXEH) jumped 28% to $1.25.
- Traeger, Inc. (NYSE: COOK) gained 24% to $3.7415 after the company announced better-than-expected Q4 results.
- AppTech Payments Corp. (NASDAQ: APCX) jumped 22.8% to $1.5350.
- Aclarion, Inc. (NASDAQ: ACON) gained 20% to $0.83.
- Berkshire Grey, Inc. (NASDAQ: BGRY) climbed 18.3% to $1.16.
- Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA) jumped 18% to $15.98
- Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS) gained 18% to $4.63.
- Boqii Holding Limited (NYSE: BQ) gained 15.7% to $1.10.
- Orla Mining Ltd. (NYSE: ORLA) climbed 13.7% to $4.55 after the company reported Q4 EPS results were higher year over year.
- Riot Platforms, Inc. (NASDAQ: RIOT) gained 10.3% to $7.78.
- Coinbase Global, Inc. (NASDAQ: COIN) surged 9.4% to $74.15.
- XPeng Inc. (NYSE: XPEV) gained 8.2% to $9.02 after the company reported a fourth-quarter FY22 sales decline of 39.9% year-on-year, to RMB5.14 billion ($745.28 million), missing the consensus of $834.05 million.
- FedEx Corporation (NYSE: FDX) rose 8% to $220.32 after the company reported better-than-expected Q3 EPS and raised its FY23 outlook.
- Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) jumped 7.4% to $13.57.
- Baidu, Inc. (NASDAQ: BIDU) gained 6.2% to $146.74 after the company announced it has been granted the first-ever permits to provide fully driverless ride-hailing service in the Chinese capital Beijing.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Lifecore Biomedical, Inc. (NASDAQ: LFCR) shares declined 61.6% to $1.9616 after the company reported worse-than-expected Q2 financial results.
- Diebold Nixdorf, Incorporated (NYSE: DBD) dropped 53.5% to $1.07. Wedbush reiterated Diebold Nixdorf with an Outperform and maintained a $5 price target.
- Acer Therapeutics Inc. (NASDAQ: ACER) fell 46.4% to $0.8313 after the company announced its Phase 2a trial data showing ACER-801 was safe and well-tolerated but did not achieve statistical significance when evaluating the ability to decrease the frequency or severity of hot flashes in postmenopausal women.
- Pear Therapeutics, Inc. (NASDAQ: PEAR) declined 44% to $0.33. Pear Therapeutics announced process exploring strategic alternatives.
- Blend Labs, Inc. (NYSE: BLND) dropped 36.5% to $0.9338 after the company reported worse-than-expected Q4 adjusted EPS and sales results.
- Nexters Inc. (NASDAQ: GDEV) shares fell 35.7% to $3.60 after the company issued Q4 update.
- Loyalty Ventures Inc. (NASDAQ: LYLT) dropped 26.8% to $0.1061.
- First Republic Bank (NYSE: FRC) dropped 26.2% to $25.23 after the bank announced a deal for $30 billion in deposits from major banks and said it has decided to suspend its dividend.
- Panbela Therapeutics, Inc. (NASDAQ: PBLA) dropped 23.5% to $0.5050 after the company reported worse-than-expected Q4 EPS results.
- Purple Innovation, Inc. (NASDAQ: PRPL) fell 21.6% to $2.5815 after the company reported worse-than-expected Q4 adjusted EPS results and issued Q1 revenue guidance below analyst estimates.
- Sarepta Therapeutics, Inc. (NASDAQ: SRPT) dropped 19.9% to $119.83 after the company said that that FDA has decided to hold a public advisory committee meeting on its SRP 9001 BLA.
- Casa Systems, Inc. (NASDAQ: CASA) fell 19.8% to $1.3950.
- Reliance Global Group, Inc. (NASDAQ: RELI) fell 19.3% to $3.1299.
- Montauk Renewables, Inc. (NASDAQ: MNTK) declined 19% to $7.70 after the company reported full year 2022 results.
- RedHill Biopharma Ltd. (NASDAQ: RDHL) fell 19% to $0.1457. RedHill Biopharma announced plan to implement ADS ratio change from a 1 ADS-for-10 ordinary shares ratio to a 1 ADS-for-400 ordinary share ratio (1-for-40) on or about March 23, 2023.
- Groupon, Inc. (NASDAQ: GRPN) fell 19% to $3.97 after the company reported worse-than-expected Q4 sales results.
- Western Alliance Bancorporation (NYSE: WAL) dropped 17.6% to $30.34. Shares of several companies in the broader financial space traded lower on continued downward momentum in the sector amid volatility and stability concerns following multiple bank failures.
- Impac Mortgage Holdings, Inc. (NYSE: IMH) fell 17.5% to $0.24 after posting a wider quarterly loss.
- Pharming Group N.V. (NASDAQ: PHAR) fell 17% to $9.94 following Q4 results.
- Semantix, Inc. (NASDAQ: STIX) dropped 16.8% to $ 3.7250.
- CareMax, Inc. (NASDAQ: CMAX) fell 16.6% to $3.0350. CareMax said it sees FY22 revenue of $631.1 million.
- Karooooo Ltd. (NASDAQ: KARO) dipped 15.8% to $22.00.
- OncoCyte Corporation (NASDAQ: OCX) fell 15% to $0.2574.
- Aspen Aerogels, Inc. (NYSE: ASPN) dropped 14.7% to $6.67.
- Dermata Therapeutics, Inc. (NASDAQ: DRMA) fell 14% to $1.90.
- PacWest Bancorp (NASDAQ: PACW) fell 13.3% to $ 9.93.
- Sunnova Energy International Inc. (NYSE: NOVA) fell 14.4% to $12.59.
- Emergent BioSolutions Inc. (NYSE: EBS) dropped 12.8% to $8.41 after JP Morgan downgraded the stock from Neutral to Underweight and lowered its price target from $23 to $9.
- Cutera, Inc. (NASDAQ: CUTR) fell 11.1% to $24.75.
- Sunrun Inc. (NASDAQ: RUN) dropped 10% to $17.10.
- Metropolitan Bank Holding Corp. (NYSE: MCB) fell 10% to $35.81.
- SL Green Realty Corp. (NYSE: SLG) dropped 9.6% to $23.77.
- Despegar.com, Corp. (NYSE: DESP) fell 9.2% to $5.01. Despegar.com recently posted downbeat quarterly results.
- Design Therapeutics, Inc. (NASDAQ: DSGN) dropped 8.8% to $6.41.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.